Patent · US Active

Dengue virus glycoprotein E DIII variants and uses thereof

US10772949B2 · kind B2 · utility

0Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2017
Grant dateSep 15, 2020
Priority date—
Expiry dateFeb 13, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Specific Dengue virus glycoprotein subunit E DIII variants and their uses in preventing and treating Dengue virus infection are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.